Heart failure & cardiomyopathiesDiagnostic or prognostic study

Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy

JACC Cardiovasc ImagingPublished

  • Prognostic cohort study
  • multicentre (3 centres)

Authors' conclusion

Myocardial LGE radiomics are strongly associated with SCD risk in HCM and provide incremental risk stratification beyond current ESC or AHA/ACC risk models.

Study context

Population
Hypertrophic cardiomyopathy (HCM) patients with late gadolinium enhancement (LGE) CMR, 3 medical centres
Participants
1,229 patients
Comparison
LGE radiomics, alone or combined, vs European Society of Cardiology (ESC) and American College of Cardiology (ACC)/American Heart Association (AHA) sudden cardiac death (SCD) risk models
Outcome
SCD risk prediction (c-statistic)

Performance

As reported in the abstract

SCD risk prediction, c-statistic
Principal radiomics (PrinRads) vs ESC
c-statistic 0.69 vs 0.57; P = 0.02
PrinRads vs ACC/AHA
c-statistic 0.69 vs 0.67; P = 0.75
PrinRads + ESC vs ESC
c-statistic 0.73 vs 0.57; P < 0.01
PrinRads + ACC/AHA vs ACC/AHA
c-statistic 0.76 vs 0.67; P < 0.01

Further findings

Individual predictors of SCD risk

ComparisonHR (95% CI)P value
One PrinRad0.57 (0.39–0.84)P = 0.01
LGE heterogeneity · major component of PrinRads0.07 (0.01–0.75)P = 0.03
OutcomeNRI (95% CI)P value
Net reclassification index — PrinRads + ESC vs ESC0.25 (0.08–0.43)P = 0.005
Net reclassification index — PrinRads + ACC/AHA vs ACC/AHA0.05 (−0.07 to 0.16)P = 0.42

SCD events · follow-up 49 ± 28 months

SCD events, whole cohort
30 (2.4%)

Original publication

Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy. JACC Cardiovasc Imaging. Published 21 June 2023. doi:10.1016/j.jcmg.2023.05.003

Summarised from the published abstract; every number is checked against it